Navigation Links
ESMO 2012 Congress: A path for medical oncology innovations
Date:6/13/2012

estions, including inherited cancers, and European screening guidelines

  • Public policy:
    • The need for harmonization of the approval process and reimbursement systems of new oncology drugs in Europe
    • Cost effectiveness and clinical trials: a new paradigm?
    • The role of cancer registries in support of planning and assessing population based oncology outcomes

  • First presentation of the findings of the International Collaborative Project on the availability and accessibility of opioids for the management of cancer pain

  • Four keynote lectures: for the first time oriented towards transversal topics, reaching beyond individual disease types, providing a topline picture of the evolution of cancer knowledge and cancer care

  • Controversy sessions: six lively and thought-provoking discussions on particularly hot topics based on latest research results

  • ESMO Clinical Practice Guidelines sessions: open discussions on individual cases to share the best of cancer care based on newly released and updated standards

  • ESMO Designated Centers of Integrated Oncology and Palliative Care announced as centers of excellence for patient care in Europe

  • ESMO Award, Hamilton Fairley Award, ESMO Lifetime Achievement Award and Georges Math Award recipients announced, to recognize prominent oncologists who have made outstanding contributions to the development of oncology and are internationally renowned for their achievements in cancer science and clinical / laboratory research

  • "2084": An inspirational and provocative play in three acts addressing the obstacles to conducting clinical research in the ever-evolving field of oncology
    "I think you're forgetting something, the authors of that trial never got prospective consent for this test to be used on archival patient's material."
    "How could they? The assay was only described two years ago!"
    "But that's not the po
    '/>"/>

  • Contact: Thomas Balasso
    media@esmo.org
    European Society for Medical Oncology
    Source:Eurekalert

    Page: 1 2 3 4

    Related biology news :

    1. Nanotechnology breakthrough could dramatically improve medical tests
    2. MADRID-MIT M+Vision Consortium hosts Biomedical Innovation Conference 2012
    3. Nuisance seaweed found to produce compounds with biomedical potential
    4. CDS Monarch Deploys DigitalPersona Strong Authentication Solutions for Secure Access to Electronic Medical Records
    5. Tufts Medical Center researchers finds marker in premies saliva predicts readiness to feed by mouth
    6. UH Case Medical Center, CardioKinetix reveal promising data for treatment for heart failure
    7. Ultrasensitive biosensor promising for medical diagnostics
    8. Medical device, health professionals attend first national conference on value-driven engineering
    9. Mainz University Medical Center attracts funding of Alexander von Humboldt Professorship
    10. Research!America says house funding levels for FY13 could undermine medical progress
    11. Miniature pressure sensors for medical touch
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:10/19/2014)... Improving household electricity access in India over the ... nation,s total carbon emissions growth during that time, ... journal Nature Climate Change ., "Energy access ... all aspects of life, including education, communication, and ... the study. , While increased energy access is ...
    (Date:10/17/2014)... Rockville, MD – Accurate knowledge regarding Ebola is critical ... current risk of hazardous global outbreak and epidemic. The ... has launched a special issue, Ebola Virus and Public ... with necessary knowledge in this critical societal moment. ... Primer on Ebola for Clinicians . The primer was ...
    (Date:10/16/2014)... Cancer constantly wages war on the human body. ... a stalemate. In pancreatic cancer, this stalemate—known as ... becoming aggressively malignant, a phenomena that is poorly ... in the laboratory of Salvatore Torquato, a Professor ... the conditions surrounding tumor dormancy and the switch ...
    Breaking Biology News(10 mins):Improved electricity access has little impact on climate change 2Modeling tumor dormancy 2
    ... found a way of stimulating the immune systems ... the devastating plaques,that are characteristic of Alzheimer's disease.,For ... a,protein-based vaccine to slow the progression of the ... created a gene-based,vaccine aimed at stimulating the immune ...
    ... cells',responsible for hearing and balance. Traditionally viewed as ... for the normal development,of nerve cells responsible for ... research. The study is reported in the January ... scientists at the University,of Washington.,"Using zebrafish as a ...
    ... essential for 'hair cells',responsible for hearing and balance. ... may be essential for the normal development,of nerve ... new,University of Utah research. The study is reported ... is co-authored by scientists at the University,of Washington.,"Using ...
    Cached Biology News:Gene vaccine for Alzheimer's disease shows promising results 2GenMAPP 2.0 released 2Harmful Bacterium Commonly Found in Poultry May Survive Refrigeration and Frozen Storage Combined 2
    (Date:10/25/2014)... October 24, 2014 Today, Nerium International, ... the winners of its “Reflect Your Youth” contest, an ... only seen a difference in their skin since using ... new outlook on life as a result of their ... as an effort by Nerium International to inspire conversations ...
    (Date:10/25/2014)... Durham, NC (PRWEB) October 24, 2014 ... appears to overcome several pitfalls of current skin grafting ... scarring and produces hair. The method, outlined in the ... a breakthrough for treating deep skin injuries that result ... skin injury completely destroys the skin’s regenerative elements. These ...
    (Date:10/25/2014)... October 24, 2014 Oramed Pharmaceuticals ... company focused on the development of oral drug delivery ... Kidron will present at FireRock Capital,s Micro-Cap Conference. ... Micro-Cap Conference ,Date: Tuesday, October 28, 2014 ,Time: 9:15am ... New York City , About ...
    (Date:10/25/2014)... Oct. 24, 2014  RegeneRx Biopharmaceuticals, Inc. (OTCBB: RGRX) ("the ... the Fourth International Symposium on Thymosins in Health and ... "When thymosin beta 4 (TB4) linked with ... peritoneal cavity in a rodent model of stroke, it ... brain parenchyma (the functional tissue of the brain).   The ...
    Breaking Biology Technology:Nerium International™ Inspires Conversation About the Journey of Aging with “Reflect Your Youth” Contest 2New engineering method shows promise for faster healing, more cosmetically appealing skin grafts 2New engineering method shows promise for faster healing, more cosmetically appealing skin grafts 3Oramed to Present at the FireRock Annual Micro-Cap Conference 2Oramed to Present at the FireRock Annual Micro-Cap Conference 3Researchers Report Thymosin Beta 4 Crosses Blood-Brain Barrier In Animal Stroke Model 2
    ... Wash., June 16, 2011 SCOLR Pharma, Inc. (OTC: ... of $1 million principal amount of its 8% Senior ... initial closing of its private offering of up to ... offer additional Debentures, up to the aggregate maximum of ...
    ... KNDL ), a leading, global full-service ... senior clinical development experts will present on important ... 47th Annual Meeting, June 19-23, 2011, in Chicago. ... benefits of hybrid monitoring; finding an economic balance ...
    ... 2011 MacuCLEAR, Inc., a specialty clinical stage pharmaceutical ... vascular disorders of the eye, announced today that Philip ... OneMedForum New York 2011 on Thursday, June 23, 2011 ... New York City.   OneMedForum will focus ...
    Cached Biology Technology:SCOLR Pharma, Inc. Announces Initial Closing of Private Placement 2SCOLR Pharma, Inc. Announces Initial Closing of Private Placement 3Kendle Experts to Address Key Industry Issues at Drug Information Association 47th Annual Meeting 2Kendle Experts to Address Key Industry Issues at Drug Information Association 47th Annual Meeting 3MacuCLEAR, Inc. to Present at OneMedForum New York 2011 and at the 2011 BIO Business Forum During the Annual BIO International Convention in Washington, D.C. 2
    Mouse monoclonal antibody raised against a partial recombinant ZNF155. NCBI Entrez Gene ID = ZNF155...
    ... macroporous polystyrene beads for hydrophobic interaction chromatography. ... adsorbing organics of molecular weight less than ... useful for the adsorption of nonpolar substances ... removal of detergents such as Triton X-100 ...
    ... : Fusion protein corresponding to ... human Mi-2 Formulation: 0.7M Tris-glycine, ... sodium azide, containing 30% glycerol ... immunoblot on Hela nuclear extract ...
    ... Phospho-Specific(Thr 222 ) ... 10 mM sodium HEPES, 100 ... 7.5. Recognizes the ~47 kDa ... (MAPKAPK-2) protein phosphorylated at Thr ...
    Biology Products: